Jasper Therapeutics Inc. (JSPR)
NASDAQ: JSPR
· Real-Time Price · USD
3.07
0.04 (1.32%)
At close: Aug 15, 2025, 3:59 PM
3.05
-0.65%
After-hours: Aug 15, 2025, 06:15 PM EDT
Jasper Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -44.39M | -21.24M | -24.32M | -18.64M | -14.58M | -13.73M | -16.58M | -17.54M | -16.08M | -14.26M | -13.21M | -11.86M | -10.4M | -2.21M | -9.06M | -3.41M | -8.41M | -9.75M |
Depreciation & Amortization | 537K | 279K | 245K | 541K | 299K | 288K | 283K | 276K | 275K | 274K | 273K | 268K | 218K | 216K | 194K | 132K | 29K | 22K |
Stock-Based Compensation | 3.63M | 1.81M | 1.97M | 2M | 1.48M | 1.17M | 1.16M | 1.4M | 1.39M | 1.27M | 1.6M | 644K | 1.06M | 778K | 231K | 195K | 295K | 327K |
Other Working Capital | 3.83M | -2.85M | -126K | 1.72M | 545K | -1.84M | -1.37M | 2.44M | 3.73M | -2.08M | 178K | 1.62M | -336K | 40K | -4.61M | 3.09M | 664K | -470K |
Other Non-Cash Items | 15.9M | -846K | 141K | 327K | 120K | 136K | 915K | -228K | -318K | 1.44M | -141K | -487K | -1.38M | -10.59M | -3.02M | -6.26M | 88K | 96K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | -831K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -50K | -450K | n/a | 3.5M |
Change in Working Capital | 8.88M | -2.85M | 831K | 1.72M | 1M | -3.6M | -1.42M | 4.12M | 1.46M | 946K | -1.17M | 1.79M | 1.14M | -2.41M | -2.89M | 2.68M | 2.21M | -387K |
Operating Cash Flow | -15.45M | -22.84M | -21.13M | -14.05M | -11.68M | -15.74M | -16.48M | -11.98M | -13.27M | -10.34M | -12.65M | -9.64M | -9.36M | -14.21M | -14.58M | -7.11M | -5.79M | -6.2M |
Capital Expenditures | -7K | n/a | -96K | -274K | -157K | -25K | -230K | n/a | -11K | -26K | -82K | -222K | -243K | -29K | -711K | -470K | -287K | -960K |
Cash Acquisitions | 8K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -138.24K | 138.24K |
Other Investing Acitivies | n/a | 4K | 20K | 182K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -218.24K | 218.24K | 138.24K |
Investing Cash Flow | 1K | 4K | -76K | -274K | -157K | -25K | -230K | n/a | -11K | -26K | -82K | -222K | -243K | -29K | -711K | -470K | -287K | -960K |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | 223K | n/a | 315K | n/a | n/a | n/a | n/a | n/a | -661 | n/a | 28K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | 47.54M | n/a | n/a | 154K | -299K | n/a | -305K | 32K | 28K | 1K | 13K | 13K | -909K | 91.73M | -600K | 2K |
Financial Cash Flow | 6.16M | n/a | 345K | 9K | 181K | 47.35M | -271K | 36K | -305K | 101.51M | 28K | 1K | 13K | 13K | -909K | 91.73M | -600K | 10.75M |
Net Cash Flow | -9.29M | -22.84M | -20.86M | -14.32M | -11.66M | 31.59M | -16.98M | -11.95M | -13.59M | 91.15M | -12.7M | -9.86M | -9.59M | -14.23M | -16.2M | 84.15M | -6.68M | 3.6M |
Free Cash Flow | -37.94M | -22.84M | -21.23M | -14.33M | -11.84M | -15.76M | -16.71M | -11.98M | -13.28M | -10.36M | -12.73M | -9.87M | -9.6M | -14.24M | -15.29M | -7.58M | -6.08M | -7.16M |